Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (BRL)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Pharmaceutical Product Distribution

          

Pharmaceutical Distribution

6.11B 7.44B 8.23B 9.72B 10.85B

CAPEX

- - - - -

Gross Profit

537M 670M 739M 866M 987M

EBITDA

- - - - -

D&A

31.84M 40.76M 43.94M 51.87M 65.43M

Operating Income

124M 176M 210M 247M 265M

Pharma Distribution (Including Specialties)

- - - - -

Gross Profit

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Drug Stores and Pharmacies

          

Pharmaceutical - Retail

1.14B 1.48B 1.75B 2.16B 2.67B

CAPEX

- - - - -

Gross Profit

371M 476M 553M 662M 762M

EBITDA

- - - - -

D&A

94.04M 97.46M 105M 118M 135M

Operating Income

-2.11M 35.63M 51.32M 63.24M 83.89M

Healthcare Equipment Distribution

          

Specialties

- - - - -

Gross Profit

- - - - -

EBITDA

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Eliminations in Related Companies

- - - - -

Gross Profit

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Intercompany Operations

-842M -1.11B -1.32B -1.73B -2.06B

Gross Profit

- - - -4.84M 1.36M

Operating Income

- - - -4.84M 1.36M

Operating Income

8.44M 31.18M 11K -5.35M -182K

D&A

- - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (BRL)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Brazil

6.41B 7.82B 8.66B 10.15B 11.45B

Total Assets

4.03B 4.36B 4.94B 5.62B 6.23B

Interest Expense

-76.16M -149M -162M -149M -201M

Income Tax Expense

-30.37M -6.07M 3.74M 5.05M -8.55M

D&A

112M 124M 133M 153M 180M

CAPEX

-82.08M -70.46M -67.53M -103M -147M

Gross Profit

908M 1.15B 1.29B 1.52B 1.75B

Net Income

78.19M 80.87M 70.4M 115M 119M

EBT

48.75M 78.97M 81.59M 128M 117M